Alnylam Pharmaceuticals (ALNY)
(Delayed Data from NSDQ)
$143.80 USD
-2.27 (-1.55%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $143.81 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Earnings News For ALNY
-
Alnylam (ALNY) Q4 Loss Narrower Than Expected, Stock Dips 10%
-
Alnylam: Q4 Earnings Snapshot
-
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Period Activity
-
Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Alnylam (ALNY) Swings to Earnings in Q3 on Collaboration Revenues
-
Alnylam: Q3 Earnings Snapshot
-
Alnylam Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Period Activity
-
Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
-
Alnylam (ALNY) Q2 Loss Wider Than Expected, Revenues Miss
-
Alnylam Pharmaceuticals (ALNY) Reports Q2 Loss, Lags Revenue Estimates
-
Alnylam: Q2 Earnings Snapshot
-
Alnylam Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Period Activity
-
Will Alnylam Pharmaceuticals (ALNY) Report Negative Q2 Earnings? What You Should Know
-
Alnylam (ALNY) Q1 Earnings Beat, Product Sales Drive Revenues
-
Alnylam Pharmaceuticals (ALNY) Reports Q1 Loss, Tops Revenue Estimates
-
Alnylam: Q1 Earnings Snapshot
-
Alnylam Pharmaceuticals Reports First Quarter 2023 Financial Results and Highlights Recent Period Activity
-
Will Alnylam Pharmaceuticals (ALNY) Report Negative Q1 Earnings? What You Should Know
-
Alnylam (ALNY) Q4 Earnings Top, Product Sales Boost Revenues
-
Alnylam: Q4 Earnings Snapshot
-
Alnylam Pharmaceuticals (ALNY) Reports Q4 Loss, Tops Revenue Estimates
-
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Period Activity
-
Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Should You Buy?
-
Alnylam's (ALNY) Earnings and Revenues Lag Estimates in Q3
-
Alnylam Pharmaceuticals (ALNY) Reports Q3 Loss, Misses Revenue Estimates